CD133+ bone marrow-derived cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD133+ bone marrow-derived cell therapy, covering 2018-03-07 to 2018-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Side Effects of Bone Marrow Derived CD133 Transplantation in Cerebral Palsy [Phase 1]